Loading...

Sino Biopharmaceutical Limited

SBHMY•PNK
Healthcare
Biotechnology
$14.29
$0.00(0.00%)
U.S. Market opens in 2h 8m

Sino Biopharmaceutical Limited (SBHMY) Stock Overview

Explore Sino Biopharmaceutical Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.8B
P/E Ratio24.25
EPS (TTM)$0.38
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$15.06
3 Months$17.40
1 Year Target$25.84

SBHMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sino Biopharmaceutical Limited (SBHMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 15.16, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $25.84.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.25 and a market capitalization of 12.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
0.60%
1-Month Change
-10.10%
3-Month Change
-19.07%
6-Month Change
-26.52%
Year-to-Date (YTD) Change
-21.60%
1-Year Change
50.69%
3-Year Change
31.66%
5-Year Change
-33.65%
All-Time (Max) Change
68.26%

Contact Information

https://www.sinobiopharm.com
852 2802 9886
Office Tower, Wan Chai, NaN, NaN

Company Facts

24,379 Employees
IPO DateSep 5, 2017
CountryHK
Actively Trading

Frequently Asked Questions